AstraZeneca Win In Seroquel Bellwether Affirmed

Law360, New York (April 6, 2010, 6:00 PM EDT) -- The U.S. Court of Appeals for the Eleventh Circuit has upheld AstraZeneca Pharmaceuticals LP's victory against one of the trial pool plaintiffs in the multidistrict litigation over the company's antipsychotic medication Seroquel, agreeing with a district court that the testimony of the plaintiff's key expert was inadmissible.

A three-judge panel said in a per curiam opinion Tuesday that Linda Guinn, whose case against AstraZeneca was chosen for an early trial but came to a halt when AstraZeneca won a motion for summary judgment, couldn't use the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.